Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2017-07-24 (8 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: POIX-TERRON (08430), Ardennes
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE CENTRALE PIXIENNE : revenue, balance sheet and financial ratios
PHARMACIE CENTRALE PIXIENNE is a French company
founded 8 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in POIX-TERRON (08430),
this company of category PME
shows in 2023 a revenue of 3.1 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE CENTRALE PIXIENNE (SIREN 831224993)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
Revenue
N/C
N/C
3 091 510 €
N/C
N/C
N/C
N/C
N/C
Net income
38 453 €
60 230 €
74 030 €
220 510 €
168 164 €
190 147 €
199 085 €
121 516 €
EBITDA
N/C
N/C
82 335 €
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
2.4%
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE CENTRALE PIXIENNE generates positive net income of 38 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2025: 122 k€ -> 38 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
38 453 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 496%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 13%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
495.928%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
13.435%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE CENTRALE PIXIENNE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
670.671
474.986
494.627
560.4
467.416
880.318
612.216
495.928
Financial autonomy
11.87
15.485
15.035
13.464
15.251
8.635
11.7
13.435
Repayment capacity
None
None
None
None
None
29.023
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
1.806%
None%
None%
Sector positioning
Debt ratio
495.932025
2023
2024
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Watch
In 2025, the debt ratio of PHARMACIE CENTRALE PIXIENNE (495.93) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
Financial autonomy
13.44%2025
2023
2024
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Watch
In 2025, the financial autonomy of PHARMACIE CENTRALE PIXIENNE (13.4%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Repayment capacity
29.02 years2023
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Watch
In 2023, the repayment capacity of PHARMACIE CENTRALE PIXIENNE (29.02) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 152.84. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
152.843
Liquidity indicators evolution PHARMACIE CENTRALE PIXIENNE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
230.56
215.232
229.333
222.323
218.241
192.337
174.444
152.843
Interest coverage
None
None
None
None
None
11.229
None
None
Sector positioning
Liquidity ratio
152.842025
2023
2024
2025
Q1: 131.48
Med: 182.6
Q3: 258.72
Average-15 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE CENTRALE PIXIENNE (152.84) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
11.23x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Excellent
In 2023, the interest coverage of PHARMACIE CENTRALE PIXIENNE (11.2x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE CENTRALE PIXIENNE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
0 €
0 €
0 €
0 €
0 €
247 877 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
24
0
0
Customer payment term (days)
0
0
0
0
0
12
0
0
Supplier payment term (days)
0
0
0
0
0
33
0
0
Positioning of PHARMACIE CENTRALE PIXIENNE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE CENTRALE PIXIENNE is estimated at
610 830 €
(range 414 512€ - 958 477€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
414k€610k€958k€
610 830 €Range: 414 512€ - 958 477€
NAF 5 année 2025
Valuation method used
Net Income Multiple
38 453 €
×
15.9x
=610 830 €
Range: 414 512€ - 958 477€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE CENTRALE PIXIENNE with other companies in the same sector:
Frequently asked questions about PHARMACIE CENTRALE PIXIENNE
What is the revenue of PHARMACIE CENTRALE PIXIENNE ?
The revenue of PHARMACIE CENTRALE PIXIENNE in 2023 is 3.1 M€.
Is PHARMACIE CENTRALE PIXIENNE profitable?
Yes, PHARMACIE CENTRALE PIXIENNE generated a net profit of 38 k€ in 2025.
Where is the headquarters of PHARMACIE CENTRALE PIXIENNE ?
The headquarters of PHARMACIE CENTRALE PIXIENNE is located in POIX-TERRON (08430), in the department Ardennes.
Where to find the tax return of PHARMACIE CENTRALE PIXIENNE ?
The tax return of PHARMACIE CENTRALE PIXIENNE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE CENTRALE PIXIENNE operate?
PHARMACIE CENTRALE PIXIENNE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart